Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

Ivim Health vs NovoCare Pharmacy

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

Ivim Health logo

Ivim Health

7.7
★★★3.9/5

Best for: budget-conscious shoppers

Visit Ivim Health
VS
NovoCare Pharmacy logo

NovoCare Pharmacy

8.7
★★★★4.4/5

Best for: branded Wegovy at the lowest manufacturer-direct self-pay price

Visit NovoCare Pharmacy

Ivim Health and NovoCare Pharmacy are both GLP-1 Providers competing for the same patients, but they make different trade-offs on price, coverage, and what's included. In our scoring, Ivim Health starts lower at $75/mo versus $149/mo, and NovoCare Pharmacy edges ahead overall (8.7 vs 7.7 out of 10). Below we break down pricing, what each plan covers, the six-dimension score, pros and cons, and exactly who should pick which.

Pricing

Ivim Health

StartingCompounded
$75/mo
semaglutide
StartingCompounded
$149/mo
tirzepatide

NovoCare Pharmacy

Wegovy pill (oral semaglutide tablets, 1.5 mg / 4 mg)oral
$149/mo
semaglutide

$149/mo for 1.5 mg and 4 mg new self-pay; 4 mg offer ends 8/31/2026, then $199/mo for 4 mg

Wegovy pen 0.25-2.4 mg (standard self-pay)Brand-name
$349$199/mo
Save 43% right now
semaglutide

$199/mo intro = first 2 monthly fills (0.25/0.5 mg) for patients new to the offer/pharmacy, through 6/30/2026; then $349/mo standard

Wegovy HD pen 7.2 mg (high-dose self-pay)Brand-name
$399/mo
semaglutide
Wegovy with commercial insurance (copay)Brand-name
$25/mo
semaglutide

with commercial insurance, as little as $25/mo; subject to max savings of $100/month

What’s included

Ivim Health

What the monthly price covers

Medication

Included

Provider visits

Included

Shipping

Not disclosed

Lab work

Not disclosed

Coaching

Included

NovoCare Pharmacy

Inclusions not disclosed.

Score breakdown

Both providers are scored on the same six-dimension framework. The gradient bar marks the stronger side on each dimension.

Ivim Health

7.7/10

Overall

NovoCare Pharmacy

8.7/10

Value25%

9.0A
vs
B
8.5

Effectiveness25%

7.5A
vs
B
9.0

User Experience15%

7.0A
vs
B
8.0

Trust & Safety15%

7.0A
vs
B
9.5

Accessibility10%

7.5A
vs
B
9.0

Support10%

7.0A
vs
B
8.0

Features & Coverage

FeatureIvim HealthNovoCare Pharmacy
Starting Price$75/mo$149/mo
Features3 features5 features
States AvailableNot disclosed50
Compounded✓ Yes
Brand Name✓ Yes
FSA/HSA Accepted
FDA WarningsNoneNone

About Ivim Health

Telehealth weight loss program with low entry-tier semaglutide pricing and a separate program fee for tirzepatide.

Read our full Ivim Health review →

About NovoCare Pharmacy

Novo Nordisk's first-party direct-to-consumer pharmacy for branded Wegovy (semaglutide). Manufacturer-owned channel: Wegovy 0.25 mg / 0.5 mg starter doses at $199/month through 6/30/2026; full-dose Wegovy at $349/month standard self-pay; Wegovy HD at $399/month. Ships nationwide. Distinct from telehealth platforms that route Wegovy through NovoCare — this is the manufacturer pharmacy itself.

Read our full NovoCare Pharmacy review →

Pros & Cons

Ivim Health

What we like

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Watch-outs

  • Limited public information on program details

NovoCare Pharmacy

What we like

  • First-party Novo Nordisk pharmacy — the most authoritative branded Wegovy channel
  • $199/mo intro pricing on Wegovy 0.25/0.5 mg starter doses (through 6/30/2026), the lowest brand self-pay price
  • $349/mo standard self-pay is well below the ~$1,300/mo retail list price
  • Ships to all 50 states with no telehealth-platform middleman fees
  • Cold-chain logistics handled directly by Novo Nordisk
  • Insurance-billing path available via the NovoCare savings program
  • NEW $149/mo Wegovy pill (oral semaglutide tablets, 1.5/4 mg) self-pay tier — 4 mg rises to $199/mo after 8/31/2026

Watch-outs

  • Wegovy only — no Ozempic, no tirzepatide, no compounded GLP-1
  • Requires an existing Wegovy prescription — no prescribing clinicians or telehealth intake
  • No clinical support included — your own prescriber handles titration and side effects
  • Manufacturer-set pricing can change at any time
  • $199 pen intro covers only the first 2 fills for new patients (through 6/30/2026); maintenance doses are $349/mo ($399 HD)

Our Verdict

Winner: NovoCare Pharmacy

NovoCare Pharmacy edges out Ivim Health with a higher overall score of 8.7/10 and is particularly strong for branded Wegovy at the lowest manufacturer-direct self-pay price. Ivim Health remains a solid alternative, especially if you're looking for budget-conscious shoppers.

Choose Ivim Health if…

You want budget-conscious shoppers and a starting price around $75/mo.

Choose NovoCare Pharmacy if…

You want branded Wegovy at the lowest manufacturer-direct self-pay price and a starting price around $149/mo.

Ready to start? Vetted GLP-1 providers

Vetted telehealth providers that prescribe GLP-1 online.

No insurance needed · vetted by our editors

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

7.3

Sunlight

Compounded GLP-1 with unlimited telehealth visits and free shipping

7.4

Care Bare Rx

LGBTQ+-inclusive compounded GLP-1 telehealth

8.5

TrimRx

Best overall value

Ivim Health vs NovoCare Pharmacy: FAQ

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Related comparisons

Continue exploring Ivim Health and NovoCare Pharmacy head-to-heads in the same category.

Or see the full category ranking.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.